5 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... cancer-associated thrombosis ... cancer-associated thrombosis ... thrombosis; PE = ... #DOAC #VTE #Malignancy
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
recommendations for thrombosis ... ) APS Venous Thrombosis ... - Arterial Thrombosis ... #APS #management ... hematology #treatment
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
form in arteries, veins ... or small-vessel thrombosis ... to be present Treatment ... target to 3-4 • DOACs ... #APS #diagnosis
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Thrombosis • Upper ... Thrombosis ... syndrome - ... Thrombosis Dr. ... #DVT #hematology
Behçet's Syndrome
Systemic disease associated with inflammation of multiple organs, small-vessel vasculitis and large-vessel vasculopathy
Epidemiology:
 • Young
also involved), Venous ... , dural sinus thrombosis ... , VTE) • Cardiac ... Treatment: • Oral ... #diagnosis #management